Molbio Diagnostics Limited’s IPO to open on August 10

Ahmedabad: Molbio Diagnostics Limited (the “Company”) proposes to open an initial public offering of its equity shares of face value of ₹1 each (“Equity Shares” and such offering the “Offer”) on Monday, August 10, 2026. The Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, being Friday, August 7, 2026. The Bid/ Offer Closing Date is Wednesday, August 12, 2026, a press release said.

As per the company, the Price Band of the Offer has been fixed from ₹ 768 per Equity Share of face value ₹1 each to ₹ 807 per Equity Share of face value ₹1 each. Bids can be made for a minimum of 18 Equity Shares of face value ₹1 each and multiples of 18 Equity Shares of face value ₹1 each thereafter.

The Offer comprises of a Fresh Issue of Equity Shares aggregating up to ₹2,000.00 million and an Offer for Sale of up to 91,66,000 Equity Shares by the Selling Shareholders.

The Equity Shares of the Company are proposed to be listed on BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”) (BSE and NSE together, the “Stock Exchanges”).

Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited and Motilal Oswal Investment Advisors Limited are the Book Running Lead Managers (“BRLMs”) to the Offer.